1 / 13

Team Meeting:

Team Meeting: Evaluating how Blockchain can transform the Pharmaceutical and Healthcare industry (White Paper) Workspace: http://www.phusewiki.org/wiki/index.php?title=Blockchain_Technology. 16-Oct-2017. Agenda: Welcome and introduce new members Sub-Groups assignment

schaub
Download Presentation

Team Meeting:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Team Meeting: Evaluating how Blockchain can transform the Pharmaceutical and Healthcare industry (White Paper) Workspace: http://www.phusewiki.org/wiki/index.php?title=Blockchain_Technology 16-Oct-2017

  2. Agenda: Welcome and introduce new members Sub-Groups assignment Use Case Selection/Criteria Timelines (100 words) 5. Vendor Calls 6. Next Steps

  3. Project members Co-leads: Adama Ibrahim (Biogen) Christopher Hart (Manchester Informatics Limited) Disa Lee Choun (UCB) Members: Farzad Faramarzi (AstraZeneca) Hariprasad Radhakrishnan (AstraZeneca) Eric Wu (Gilead) Anders Bergkvist (Merck) AjiBarot (HealthUnlocked) Fernand Maes (Johnson&Johnson) Zakaria Arrassi (UCB) Marc Casals (UCB) Yusuf Ghadiali (Biogen) Imran Shakur (Biogen) Richard Shute (Curlewresearch) Bob Clay (Regulatory) Matt McClain (Lilly) Kenneth Ng (Hashed Health) Philip Clothiaux (Hashed Health) 18 Project Members!

  4. Sub-work group assignments Group 1. Introduce BlockChain and describe how it works, what are the benefits, etc. + high level use case to explain the technology, + two detailed use cases. Sub Group Leader: Aji Group 2. Pre-requisites to adopt BlockChain: Regulatory/FDA statement, IT and Pharma/Healthcare landscape, "are we ready for blockchain", + two detailed use cases Sub Group Leader: Chris Group 3. Understand the qualities of BlockChain relevant to the i.e. 2 chosen use cases. Provide high level analysis of Pros/Cons Example Use cases (detailed): TEAM TO AGREE Clinical, Data Sharing Supply Chain Sub Group Leader: Adama

  5. Use Case Criteria FROM IBM ID Business Problem ID business network (touch points not just two people, has to be complex and a network by definition) Need for trust to be intact Need for consensus/agreement/contract Need to Provenance Need for Mutability (cannot be modified) Need for finality ( agree as single source of truth, no reconciliation) Based on Blockchain Characteristics? increases trust reduces costs simplifies process eases worker burden (increases productivity) makes fraud harder eases regulatory assurance Any other pharma-related criteria?

  6. Project Deliverable and Timelines

  7. Project Plan- timelines

  8. Vendor Calls Face to Face Meeting at UCB offices on the 20th Oct 2017 Pokitdok IBM Matt Consulting Group Richard Shute Delloitte IEEE Other

  9. Next Steps.. Continue with research/attending vendor calls if available Meet in Sub-workgroups twice a month for the next 2 months Work on write up and review Try to meet face to face if possible (conferences) Share the template (PhUSE workspace) to start writing each section by sub-workgroups

  10. Thank you

  11. Back-up slides

  12. Project Scope Introduce BlockChain and describe how it works Pre-requisites to adopt BlockChain Understand the qualities of BlockChain relevant to the Pharma setting and the example of use cases and applications Provide high level analysis of Pros/Cons of BlockChain in Pharma and Healthcare Emerging Trends & Technology Educating for the future

  13. Risk

More Related